RNU6-864P

Across TCGA pan-cancer cohorts, RNU6-864P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-864P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RNU6-864P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-864P expression acts as an unfavorable survival marker.

COAD, LIHC, and KIRC are the cancer types where RNU6-864P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.159	0.801	.001	108	view →
LIHC	DFS	Tertile	All	0.064	0.558	<.001	102	view →
KIRC	DFS	Tertile	IV	0.038	0.632	<.001	60	view →
STAD	OS	Tertile	II,III,IV	0.480	0.669	.016	57	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
HNSC	DFS	Tertile	II,III,IV	0.194	0.661	.031	27	view →
LUSC	DFS	Tertile	All	0.337	0.663	.031	18	view →
UCEC	DFS	Tertile	II,III,IV	0.223	0.736	.027	18	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-864P–COAD (OS)

Open the COAD breakdown →